SKINMEDICA ACNE TREATMENT- benzoyl peroxide lotion 
Allergan, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

SkinMedica Acne Treatment Lotion

Drug Facts

Active ingredient

Benzoyl Peroxide 2.5%

Purpose

Acne Treatment

Use

  • For the treatment of acne
  • Dries up acne pimples. Helps prevent new acne pimples

Warnings

For external use only

Do not use if you

  • Have very sensitive skin
  • Are sensitive to benzoyl peroxide

When using this product

  • Skin irritation and dryness is most likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time
  • Avoid unnecessary sun exposure and use a sunscreen
  • Avoid contact with the eyes, lips, and mouth
  • Avoid contact with hair and dyed fabrics, which may be bleached by this product
  • Skin irritation may occur, characterized by redness, burning, itching, peeling, or possibly swelling. Irritation may be reduced by using the product less frequently or in a lower concentration

Stop use and ask a doctor if

  • Irritation becomes severe

Keep out of reach of children

If swallowed, get medical help or contact a Poison Control Center right away.

Directions AM/PM

  • Clean the skin thoroughly before applying this product
  • Cover the entire affected area with a thin layer one to three times daily
  • Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
  • If bothersome dryness or peeling occurs, reduce application to once a day or every other day
  • If going outside, apply sunscreen after using this product. If irritation develops, stop use of both products and ask a doctor
  • Sensitivity Test for a New User. Apply product sparingly to one or two small affected areas during the first 3 days. If no discomfort occurs, follow the directions stated above

Other information

Store at controlled room temperature 15° - 30°C (59° - 86°F)

Inactive ingredients

Water, Methyl Methacrylate/Glycol Dimethylacrylate Crosspolymer, C12-15 Alkyl Benzoate, Polyacrylate-13, Hydroxyphenyl Propamidonezoic Acid, Salix Nigra (Willow) Bark Extract, Hamamelis Virgiana (Witch Hazel) Bark/Leaf/Twig Extract, Salvia Officinalis (Sage) Leaf Extract, Allantoin, Bisabolol, Butylene Glycol, Pentylene Glycol, Xanthan Gum, Polyisobutene, Polysorbate 20, Disodium EDTA, Ethylhexylglycerin, Phenoxyethanol, Potassium Sorbate

SkinMedica®

Acne Treatment
Lotion

This elegantly formulated benzoyl peroxide-based therapeutic lotion fights the causes of acne, restoring balance to the skin for a more healthy and radiant complexion.

ACNE

Net Wt. 56.7 g / 2 Oz.

Carton
SKINMEDICA ACNE TREATMENT 
benzoyl peroxide lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0023-4965
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
benzoyl peroxide (UNII: W9WZN9A0GM) (benzoyl peroxide - UNII:W9WZN9A0GM) benzoyl peroxide25 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
allantoin (UNII: 344S277G0Z)  
levomenol (UNII: 24WE03BX2T)  
butylene glycol (UNII: 3XUS85K0RA)  
alkyl (C12-15) benzoate (UNII: A9EJ3J61HQ)  
edetate disodium (UNII: 7FLD91C86K)  
ethylhexylglycerin (UNII: 147D247K3P)  
hamamelis virginiana root bark/stem bark (UNII: T7S323PKJS)  
hydroxyphenyl propamidobenzoic acid (UNII: 25KRT26H77)  
methyl methacrylate/glycol dimethacrylate crosspolymer (UNII: EG97988M5Q)  
pentylene glycol (UNII: 50C1307PZG)  
phenoxyethanol (UNII: HIE492ZZ3T)  
Polysorbate 20 (UNII: 7T1F30V5YH)  
Polyisobutylene (35000 MW) (UNII: 98553S1MHQ)  
Potassium Sorbate (UNII: 1VPU26JZZ4)  
Salix Nigra Bark (UNII: QU52J3A5B3)  
Sage (UNII: 065C5D077J)  
water (UNII: 059QF0KO0R)  
Xanthan Gum (UNII: TTV12P4NEE)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0023-4965-021 in 1 CARTON01/01/2013
156.7 g in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH FINALpart333D01/01/201307/30/2020
Labeler - Allergan, Inc. (144796497)

Revised: 3/2013
Document Id: cd0d19ec-38e9-42c8-8d52-5d46c13a22b5
Set id: afab1c0d-6169-493d-b8ee-3ad3288a66e7
Version: 7
Effective Time: 20130301
 
Allergan, Inc.